On the other hand, since ACE2 is the receptor for SARS-CoV-2 entry, some authors have speculated about a greater susceptibility to viral infection and disease severity upon the use of ACE-Is and ARBs [34]. The gene discussed is ACE2; the disease is viral infectious disease.